Search Results - Jeffrey Leibowitz
- Showing 1 - 1 results of 1
-
1
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab by Douglas I. Lin, Julia C. F. Quintanilha, Natalie Danziger, Lixin Lang, Diane Levitan, Cynthia Hayne, Matthew C. Hiemenz, David L. Smith, Lee A. Albacker, Jeffrey Leibowitz, Douglas A. Mata, Brennan Decker, Sotirios Lakis, Nimesh R. Patel, Ryon P. Graf, Julia A. Elvin, Jeffrey S. Ross, Varun Pattani, Richard S. P. Huang, Amy K. Wehn
Published in npj Precision Oncology (2024-09-01)Get full text
Article
